IN2014DN09416A - - Google Patents

Info

Publication number
IN2014DN09416A
IN2014DN09416A IN9416DEN2014A IN2014DN09416A IN 2014DN09416 A IN2014DN09416 A IN 2014DN09416A IN 9416DEN2014 A IN9416DEN2014 A IN 9416DEN2014A IN 2014DN09416 A IN2014DN09416 A IN 2014DN09416A
Authority
IN
India
Prior art keywords
microspheres
api
manufacture
present
dispersions
Prior art date
Application number
Other languages
English (en)
Inventor
Cecil W Propst
Marc W Meadows
Michael S Todd
Original Assignee
Spi Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spi Pharma Inc filed Critical Spi Pharma Inc
Publication of IN2014DN09416A publication Critical patent/IN2014DN09416A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1617Organic compounds, e.g. phospholipids, fats
    • A61K9/1623Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00Stock material or miscellaneous articles
    • Y10T428/29Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982Particulate matter [e.g., sphere, flake, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN9416DEN2014 2012-04-25 2013-04-25 IN2014DN09416A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261638073P 2012-04-25 2012-04-25
US201361783603P 2013-03-14 2013-03-14
PCT/US2013/038257 WO2013163453A1 (en) 2012-04-25 2013-04-25 Crystalline microspheres and the process for manufacturing the same

Publications (1)

Publication Number Publication Date
IN2014DN09416A true IN2014DN09416A (ru) 2015-07-17

Family

ID=49483900

Family Applications (1)

Application Number Title Priority Date Filing Date
IN9416DEN2014 IN2014DN09416A (ru) 2012-04-25 2013-04-25

Country Status (9)

Country Link
US (5) US9089487B2 (ru)
EP (2) EP3583935A1 (ru)
JP (2) JP6577865B2 (ru)
BR (1) BR112014026351B1 (ru)
CA (1) CA2871429C (ru)
ES (1) ES2729035T3 (ru)
IN (1) IN2014DN09416A (ru)
MX (1) MX359554B (ru)
WO (1) WO2013163453A1 (ru)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL219362A (en) 2012-04-23 2017-04-30 Verint Systems Ltd A system and method for predicting threatened points of interest
MX359554B (es) 2012-04-25 2018-10-02 Spi Pharma Inc Microesferas cristalinas y proceso para fabricacion de las mismas.
US10560842B2 (en) 2015-01-28 2020-02-11 Verint Systems Ltd. System and method for combined network-side and off-air monitoring of wireless networks
IL242354B (en) 2015-10-29 2019-09-26 Verint Systems Ltd System and method for identifying genuine base stations that serve rogue base stations
IL245299B (en) 2016-04-25 2021-05-31 Verint Systems Ltd A system and method for decoding communication transmitted in a wireless local communication network
US10639312B1 (en) * 2019-12-06 2020-05-05 Edenbridge Pharmaceuticals, LLC Finished pharmaceutical dosage form of a methenamine salt such as methenamine mandelate

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4820627A (en) * 1986-03-24 1989-04-11 Em Diagnostic Systems, Inc. Method of preparing particles suitable for tabletting into diagnostic reagents
JPH0192403A (ja) 1987-09-30 1989-04-11 Aprica Kassai Inc 使い捨ておむつ
FR2670398B1 (fr) * 1990-12-14 1995-02-17 Roquette Freres Composition pulverulente directement compressible et procede d'obtention.
US5573783A (en) 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
US6548095B1 (en) 1996-08-24 2003-04-15 Südzucker Aktiengesellschaft Sugar-free compressed products
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation
US5780055A (en) 1996-09-06 1998-07-14 University Of Maryland, Baltimore Cushioning beads and tablet comprising the same capable of forming a suspension
JP3447042B2 (ja) * 1997-07-23 2003-09-16 フロイント産業株式会社 単一物質球形粒の製造方法
GB9716432D0 (en) * 1997-08-05 1997-10-08 Cerestar Holding Bv Tableting of erythritol
JP2000128774A (ja) 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
US6248363B1 (en) 1999-11-23 2001-06-19 Lipocine, Inc. Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU2002226098A1 (en) * 2000-10-30 2002-05-15 The Board Of Regents, The University Of Texas System Spherical particles produced by a hot-melt extrusion/spheronization process
US20030129250A1 (en) * 2001-11-20 2003-07-10 Advanced Inhalation Research Inc. Particulate compositions for improving solubility of poorly soluble agents
US7118765B2 (en) 2001-12-17 2006-10-10 Spi Pharma, Inc. Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms
EP2087882A1 (en) * 2002-03-26 2009-08-12 Teva Pharmaceutical Industries Ltd. Drug microparticles
GB0228826D0 (en) * 2002-12-11 2003-01-15 Okpala Joseph Hair technology in creating particles with improved delivery capabilities
WO2004067595A2 (en) * 2003-01-29 2004-08-12 Spi Polyols, Inc. Compositions of polyol granules and processes of manufacture
EP1646354A4 (en) * 2003-07-22 2010-03-17 Baxter Int SMALL SPHERICAL PARTICLES OF LOW MOLECULAR WEIGHT MOLECULES AND PROCESSES FOR THEIR PREPARATION AND USE
US20070092562A1 (en) 2003-10-28 2007-04-26 Spi Pharma, Inc. Product and process for increasing compactibility of carbohydrates
WO2005044193A2 (en) * 2003-10-28 2005-05-19 Spi Pharma, Inc. Product and process for increasing compactibility of carbohydrates
BRPI0417348A (pt) 2003-12-04 2007-03-13 Pfizer Prod Inc processo de gelatinização por spray com utilização de uma extrusora para preparação de composições de droga cristalina multiparticulada contendo preferencialmente um poloxámero e um glicerìdeo
CN103393601A (zh) 2004-05-12 2013-11-20 巴克斯特国际公司 含有蛋白并在高浓度蛋白下显示可注射性的微球体
WO2006058250A2 (en) 2004-11-24 2006-06-01 Spi Pharma, Inc. Orally disintegrating compositions
EP1887027B1 (en) * 2005-04-06 2011-06-08 Sanyo Chemical Industries, Ltd. Resin particle and resin dispersion
JP2007217651A (ja) * 2006-02-20 2007-08-30 Daicel Chem Ind Ltd 環状ポリオレフィン系樹脂の球状粒子およびその製造方法
PL2046269T3 (pl) * 2006-08-01 2011-05-31 Procter & Gamble Cząstka dostarczająca zawierająca korzystny środek
WO2008065504A1 (en) 2006-11-30 2008-06-05 Pfizer Products Inc. Multiparticulates of spray-coated drug and polymer on a meltable core
WO2008094877A2 (en) 2007-01-30 2008-08-07 Drugtech Corporation Compositions for oral delivery of pharmaceuticals
US8883307B2 (en) * 2007-05-28 2014-11-11 Mitsubishi Shoji Foodtech Co., Ltd. Spherical particle of crystalline mannitol
JP5258268B2 (ja) 2007-11-19 2013-08-07 フロイント産業株式会社 球形粒の製造方法
BRPI0912589A2 (pt) * 2008-08-18 2015-10-13 Mitsubishi Shoji Foodtech Co Ltd "excipiente para comprimidos composto de novo manitol esférico"
WO2010104563A2 (en) 2009-03-09 2010-09-16 Spi Pharma, Inc. Highly compactable and durable direct compression excipients and excipient systems
DK2427177T3 (en) * 2009-05-08 2018-06-18 Emplicure Ab Composition for prolonged drug delivery comprising geopolymer binder
JP2011157348A (ja) * 2010-01-05 2011-08-18 Fuji Chem Ind Co Ltd 崩壊性高強度球状粒子組成物
DE102010045479A1 (de) 2010-09-16 2014-10-30 Brace Capital Gmbh Verfahren zur Mikroverkapselung, Herstellung von festen Formen mehrphasiger mischbarer und nichtmischbarer Materialien und Methode zur Herstellung vorgenannter Systeme
AU2011305572B2 (en) 2010-09-20 2016-08-04 Diane Goll Microencapsulation process and product
MX359554B (es) * 2012-04-25 2018-10-02 Spi Pharma Inc Microesferas cristalinas y proceso para fabricacion de las mismas.

Also Published As

Publication number Publication date
MX2014012805A (es) 2015-01-22
EP2841057A4 (en) 2015-09-16
BR112014026351A2 (pt) 2017-06-27
JP2019112438A (ja) 2019-07-11
MX359554B (es) 2018-10-02
CA2871429A1 (en) 2013-10-31
EP2841057A1 (en) 2015-03-04
WO2013163453A1 (en) 2013-10-31
JP6577865B2 (ja) 2019-09-18
US20220151932A1 (en) 2022-05-19
US20150140097A1 (en) 2015-05-21
EP3583935A1 (en) 2019-12-25
CA2871429C (en) 2018-07-31
US10245232B2 (en) 2019-04-02
US11278496B2 (en) 2022-03-22
US20190224126A1 (en) 2019-07-25
US9089487B2 (en) 2015-07-28
ES2729035T3 (es) 2019-10-29
US20160015640A1 (en) 2016-01-21
BR112014026351B1 (pt) 2022-09-27
EP2841057B1 (en) 2019-03-20
US20140099372A1 (en) 2014-04-10
JP2015514809A (ja) 2015-05-21

Similar Documents

Publication Publication Date Title
IN2014DN09416A (ru)
WO2012088266A3 (en) Substituted imidazopyridazines and benzimidazoles as inhibitors of fgfr3
MX2013001677A (es) Formulaciones estables de linaclotida.
MX2019014200A (es) Formulaciones eutecticas de clorhidrato de ciclobenzaprina y de clorhidrato de amitriptilina.
SG11201406141UA (en) Immortalized stem cells and medicinal composition and medicinal preparation comprising product thereof as active ingredient
PH12015501096A1 (en) Composition for immediate and extended release
WO2013134534A3 (en) Solid state forms of cabazitaxel and processes for preparation thereof
PH12014502512A1 (en) Topical pharmaceutical compositions comprising terbinafine and urea
TN2013000386A1 (en) Suspension type topical formulations comprising cyclic depsipeptide
MX340188B (es) Elaboracion de granulos sin activos y tabletas que comprenden los mismos.
MX2016001422A (es) Composicion farmaceutica de fingolimod.
PH12016502544B1 (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
NZ628451A (en) Dehydrated plant-derived products and methods for making the same
TR201009167A2 (tr) Sefalosporin içeren farmasötik granüller.
MX369549B (es) Un proceso para la fabricación de núcleos de tabletas duros con recubrimiento.
TN2015000267A1 (en) Solid unit with high fexofenadine content and process for the preparation thereof
MX356373B (es) Composiciones que comprenden un agente antibacterial y tazobactam.
MX2019012375A (es) Formulaciones del inhibidor del antigeno-1 asociado a la funcion de linfocitos (lfa-1).
WO2016195194A3 (ko) 신규한 tlr2 길항제
WO2012007758A3 (en) Pharmaceutical formulations
IN2014DN07897A (ru)
MX2013011884A (es) Composiciones farmaceuticas de liberacion modificada de desvenlafaxina.
IN2012CH05549A (ru)
WO2011139255A3 (en) Pharmaceutical compositions comprising cefetamet
MX2015011101A (es) Composiciones farmaceuticas de donepezilo que tienen un perfil de disolución in vitro o parámetros farmacocinéticos específicos.